General Information of the Compound
| Compound ID |
CP0850591
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-(2-(3,4-dichlorobenzyl)pyrrolidin-1-yl)(2-methyl-5-(m-tolyl)thiazol-4-yl)methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H22Cl2N2OS
|
||||||||||||||||||
| Molecular Weight |
445.415
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc(Cl)c(Cl)c2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H22Cl2N2OS/c1-14-5-3-6-17(11-14)22-21(26-15(2)29-22)23(28)27-10-4-7-18(27)12-16-8-9-19(24)20(25)13-16/h3,5-6,8-9,11,13,18H,4,7,10,12H2,1-2H3/t18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KSPVDNDDUKZZQK-SFHVURJKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1